• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21721 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab treated patients – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Selective tubal occlusion (Essure) for female sterilisation - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Nitisinone for hereditary tyrosinaemia type 1 (HT-1) - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Alemtuzumab (MabCampath) for chronic lymphocytic leukaemia (first-line): horizon scanning technology ultra-orphan note
2013     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer – second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Onartuzumab for metastatic Met positive non-small cell lung cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Crizotinib (Xalkori) for ALK-positive, locally advanced or metastatic, non-small cell lung cancer — first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab naïve patients – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Sildenafil for female sexual arousal disorder - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Miglustat for type 3 Gaucher's, Niemann-Pick type C and lateonset Tay-Sachs disease - horizon scanning review [withdrawn]
2013     NIHR Horizon Scanning Centre (NIHR HSC) Apixaban (Eliquis) for the treatment and prevention of venous thromboembolic events
2015     NIHR Horizon Scanning Centre (NIHR HSC) Erythrocyte encapsulated asparaginase (GRASPA) for acute lymphoblastic leukaemia — second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for recurrent or metastatic squamous cell carcinoma of the head and neck – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Thalidomide for multiple myeloma - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) StaphVAX for the prevention of Staphylococcus aureus infections in end stage renal disease - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sutent (sunitinib malate) for gastrointestinal stromal tumour (GIST): horizon scanning technology ultra-orphan note
2013     NIHR Horizon Scanning Centre (NIHR HSC) Erismodegib for locally advanced or metastatic basal cell carcinoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) LCZ696 for chronic heart failure – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) with paclitaxel and carboplatin for stage IV or recurrent non-small cell lung cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Olaratumab with doxorubicin for advanced soft tissue sarcoma
2002     NIHR Horizon Scanning Centre (NIHR HSC) Theratope for breast cancer - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Cinacalcet HCl for secondary hyperparathyroidism - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for chemotherapy-naïve hormone-relapsed metastatic prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for advanced or metastatic urothelial cancer – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Transpupillary thermotherapy for age-related macular degeneration - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate for primary deep vein thrombosis prevention post hip and knee surgery: horizon scanning technology briefing
2013     NIHR Horizon Scanning Centre (NIHR HSC) LCQ908 (Pradigastat) for familial chylomicronaemia syndrome – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Padeliporfin (Tookad soluble) for localised prostate cancer – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Tirapazamine for non-small cell lung cancer - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab for psoriasis - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Gevokizumab for chronic non-infectious uveitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Alicaforsen for pouchitis – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pegaspargase (Oncaspar) for acute lymphoblastic leukaemia
2015     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib (Stivarga) for hepatocellular carcinoma – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Tissue engineered heart valves - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (avastin) for advanced and metastatic breast cancer (stages III and IV): horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) ABT-450/ritonavir/ABT-267 in combination with ABT-333 for chronic genotype-1 hepatitis C infection
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine (Kadcyla) for patients with HER2 positive locally advanced or metastatic relapsed gastric cancers
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rindopepimut for EGFRvIII positive glioblastoma multiforme - first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib for advanced hormone receptor positive, HER2 negative breast cancer – first line
2003     NIHR Horizon Scanning Centre (NIHR HSC) AC2993 for type 2 diabetes - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (avastin) for advanced renal cell carcinoma: horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab for hepatocellular cancer – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rociletinib for advanced or recurrent non-small cell lung cancer with the EGFR T790M mutation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) AXS 02 (zoledronic acid) for type I complex regional pain syndrome
2003     NIHR Horizon Scanning Centre (NIHR HSC) Agomelatine for depression - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Oncophage for renal cell carcinoma - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Leuco-methylthioninium for alzheimer's disease
2013     NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone (Pixuvri) in combination with rituximab for diffuse large B-cell lymphoma or grade 3 follicular lymphoma – second and subsequent line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) for relapsed chronic lymphocytic leukaemia – in combination with bendamustine and rituximab
2015     NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease – patients in remission
2003     NIHR Horizon Scanning Centre (NIHR HSC) Alvimopan for post-operative ileus - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib tosylate (nexavar) for advanced renal cell carcinoma: horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Miniprobes™ for probe-based confocal laser endomicroscopy in bladder, pancreatic or bile duct cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed chronic lymphocytic leukaemia
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for metastatic hormone-relapsed prostate cancer following docetaxel treatment and radiotherapy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed chronic lymphocytic leukaemia – second and subsequent line
2003     NIHR Horizon Scanning Centre (NIHR HSC) BEC-2 for small cell lung cancer - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib for advanced hepatocellular carcinoma (HCC): horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
2013     NIHR Horizon Scanning Centre (NIHR HSC) IceSense3™ Cryoablation System for breast fibroadenoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) MEK162 for NRAS mutation positive advanced malignant melanoma – first and second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lanreotide for unresectable, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) for relapsed or refractory acute lymphoblastic leukaemia – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed follicular lymphoma - third and subsequent line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for multiple myeloma - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices for cardiac arrhythmia - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for locally advanced, recurrent or metastatic head and neck squamous cell carcinoma – second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) EndoVE® for colorectal cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced melanoma – first or second line, in patients naïve to ipilimumab
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced melanoma – second or third line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2003     NIHR Horizon Scanning Centre (NIHR HSC) CPH82 for rheumatoid arthritis - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Implantable miniature telescopes for advanced, untreatable age-related macular degeneration: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) AIN-457 for posterior uveitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Astuprotimut-r (Zumagev) for stage III, MAGE-A3 positive malignant melanoma – adjuvant therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Curodont™ Repair and Curodont Protect™ for the treatment and prevention of tooth decay
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced or recurrent PD-L1 positive non-small cell lung cancer – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation– negative advanced melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Eprodisate disodium (Kiacta) for AA amyloidosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for relapsed or refractory peripheral T-cell lymphoma
2003     NIHR Horizon Scanning Centre (NIHR HSC) Drugs for irritable bowel syndrome - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Grazax allergy vaccine for moderate to severe seasonal allergic rhinitis (grass pollen hay fever): horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Apixaban for stroke prevention in atrial fibrillation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for HER2-positive breast cancer – adjuvant therapy in combination with or following trastuzumab
2013     NIHR Horizon Scanning Centre (NIHR HSC) ARGOS-IO for the measurement of intraocular pressure in glaucoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for newly diagnosed glioblastoma multiforme – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation-positive advanced melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) STG 320 for allergic rhinitis
2003     NIHR Horizon Scanning Centre (NIHR HSC) Duloxetine for female stress urinary incontinence - horizon scanning review